GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
176 hedge funds and large institutions have $2.41B invested in Global Blood Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% more funds holding
Funds holding: 157 → 176 (+19)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Holders
176
Holding in Top 10
6
Calls
$56.3M
Puts
$32.2M
Top Buyers
| 1 | +$107M | |
| 2 | +$78.9M | |
| 3 | +$32.5M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$30M |
| 5 |
Renaissance Technologies
New York
|
+$29.6M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$32.2M | |
| 3 | -$16.9M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$13.4M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$12.8M |